Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Conference Call August 3, 2023 8:45 AM ET Company Participants Lisa Caperelli - VP of IR Bill Collier - President, CEO and Director David Hastings - CFO Karen Sims - VP of Clinical Development Michael Sofia - Chief Scientific Officer Conference Call Participants Roy Buchanan - JMP Dennis Ding - Jefferies Operator Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised ...